Beta-2 microglobulin (B2M) antibody and antigen (Recombinant protein)
Diagnostic Beta-2 microglobulin (B2M) antibodies (anti-Beta-2 microglobulin, anti-B2M) and antigens (recombinant Beta-2 microglobulin (B2M) protein) for Kidney function (renal damages) B2M detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-B2M-Ag01 | Recombinant human B2M/CDABP0092/HDCMA22P Protein | 3090 |
GMP-h-B2M-Ab01 | Anti-human B2M/CDABP0092/HDCMA22P mouse monoclonal antibody (mAb) | 1953 |
GMP-h-B2M-Ab02 | Anti-human B2M/CDABP0092/HDCMA22P mouse monoclonal antibody (mAb) | 1953 |
GMP-h-B2M-Ab03 | Anti-human B2M/CDABP0092/HDCMA22P human monoclonal antibody (mAb) | 1953 |
GMP-h-B2M-Ab04 | Anti-human B2M/CDABP0092/HDCMA22P human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-h-B2M-Ag01 |
Product Name | Recombinant human B2M/CDABP0092/HDCMA22P Protein |
Target/Biomarker | Beta-2 microglobulin (B2M) |
Alias of Target/Biomarker | AMYLD6, IMD43, MHC1D4 |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | Beta-2 microglobulin (B2M) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in B2M level test of Kidney function (renal damages) (renal disease) and related syndrome evaluation. |
Tag | His |
Products description | Recombinant human B2M/CDABP0092/HDCMA22P Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-B2M-Ab01, GMP-h-B2M-Ab02 |
Product Name | Anti-human B2M/CDABP0092/HDCMA22P mouse monoclonal antibody (mAb) |
Target/Biomarker | Beta-2 microglobulin (B2M) |
Alias of Target/Biomarker | AMYLD6, IMD43, MHC1D4 |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Beta-2 microglobulin (B2M) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in B2M level test of Kidney function (renal damages) (renal disease) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human B2M/CDABP0092/HDCMA22P mouse monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-B2M-Ab03, GMP-h-B2M-Ab04 |
Product Name | Anti-human B2M/CDABP0092/HDCMA22P human monoclonal antibody (mAb) |
Target/Biomarker | Beta-2 microglobulin (B2M) |
Alias of Target/Biomarker | AMYLD6, IMD43, MHC1D4 |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Beta-2 microglobulin (B2M) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in B2M level test of Kidney function (renal damages) (renal disease) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human B2M/CDABP0092/HDCMA22P human monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
What is Beta-2 microglobulin (B2M) test? Beta-2 microglobulin (B2M) is a protein that is found on the surface of nucleated cells (contain a nucleus) and functions as part of the immune system. This protein is routinely shed by cells into the blood and is present in most body fluids, with highest levels in the blood, generally lower levels in spinal fluid, and trace levels in urine. In the kidneys, B2M passes through blood-filtering units called the glomeruli and is then reabsorbed by the renal proximal tubules, structures that reclaim water, proteins, vitamins, minerals, and other vital substances. Normally, only small amounts of B2M are present in the urine, but when the renal tubules become damaged or diseased, B2M concentrations increase due to the decreased ability to reabsorb this protein. When the glomeruli in the kidneys are damaged, they are unable to filter out B2M, so the level in the blood rises.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments